Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review

BACKGROUND: Diabetic retinopathy (DR) is a significant global public health and economic burden. DR accounts for approximately 15–17% of all cases of total blindness in the USA and Europe. Telemedicine is a new intervention for DR screening, however, there is not enough evidence to support its cost-...

Descripción completa

Detalles Bibliográficos
Autores principales: Avidor, Daniel, Loewenstein, Anat, Waisbourd, Michael, Nutman, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137317/
https://www.ncbi.nlm.nih.gov/pubmed/32280309
http://dx.doi.org/10.1186/s12962-020-00211-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137317/
https://www.ncbi.nlm.nih.gov/pubmed/32280309
http://dx.doi.org/10.1186/s12962-020-00211-1

Ejemplares similares